Medicine prices to drop
The Ministry of Health announced today that it will greatly reduce the price of thousands of pharmaceutical drugs and other medicines.In the first stage, the price reduction of 67 of the drugs will take effect on July 1. Price reductions on another 498 drugs in that stage will go into effect on September In the second stage, to be announced by the middle of Ramadan or after Ramadan, the price of about 2,000 generic medicines will be reduced, officials said.There are 8,500 medicines registered in the UAE, including conventional medicines, herbs and food supplements.In the first stage of the price reduction, the ministry has concentrated on innovative medicines. The price reduction in this stage will be from 5 per cent to 60 per cent. Twenty pharmaceutical companies have already reduced the prices of some of their drugs.In the second stage, officials are looking to reduce the price of about 2,000 generic medicines that have been produced in the US and Arab countries. Those price changes will be announced either by the middle of Ramadan or after Ramadan. The amount of the reductions in the second phase has not yet been announced.Also today, Ministry of Health officials announced that they have licensed the world's first oral medication for multiple sclerosis. The UAE is the first country in the Gulf region to approve the medicine.It has also been approved in the US, Russia, Canada, Australia, Argentina, Switzerland and Europe.The medication costs about Dh10,800 per pack. A representative from the head of the patient affairs committee of the UAE MS support group welcomed the introduction of the medication since it provides another opportunity to treat MS patients. "... There is the burden on residents in the UAE, which is affording expensive MS treatment," said Maha Raisi, the director of patient affairs at the UAE MS Support Group.Although the new drug has already been made available in a few select pharmacies and hospitals in Dubai, credited to backing from the Dubai Health Authority, it was not announced as an officially registered medication by the Ministry of Health until today.
Subscribe to:
Post Comments (Atom)
Superhit News
-
US health regulator USFDA has issued a warning letter to German drug firm Fresenius Kabi AG for lapses at its drug manufacturing fac...
-
Goods and Service Tax (GST) is high on the agenda for the new government and its rollout is a priority. GST will benefit the Indian pharma...
-
Rib-X Pharmaceuticals, Inc. announced today the signature of an exclusive worldwide research collaboration agreement and option for license ...
-
Physiomics: Reports difficult trading but highlights growing interest from big pharmaceutical groupsPhysiomics ( LON:PYC ) said that trading conditions were difficult in the six months ended 31 December 2010, but it believes it is in a be...
-
Hindusthan National Glass and Industries Ltd is expected to finalize a strategic overseas acquisition in the pharmaceuticals space in the n...
-
The Minister of State (Health and Family Welfare), Sh Ashwini Kumar Choubey through a written reply in the Lok Sabha informed about th...
-
The government is hoping to see the implementation of the track and trace system for domestic and export supply chain in another one y...
-
India's Central Drugs Standard Control Organization (CDSCO) has suspended the manufacturing of eye drops at the Chennai-based firm after...
-
Diclofenac injection is a painkiller which is manufactured by Themis Medicare Ltd and marketed by Novartis India under the brand name ...
-
Amylin Pharmaceuticals, Inc. AMLN +16.15% and Alkermes plc ALKS +4.61% today announced that the U.S. Food and Drug Administration (FDA) has ...
No comments:
Post a Comment